Common Contracts

EX-4.29 12 dex429.htm PATENT LICENSE AGREEMENT - EXCLUSIVE * CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN *. NATIONAL INSTITUTES OF...

Patent License Agreement • May 5th, 2020 • District of Columbia

• Contract Type
  Patent License Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  District of Columbia

This Patent License Agreement, hereinafter referred to as the “Agreement” consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (Patent or Patent Application), Appendix B (Fields of Use and Territory), Appendix C (Royalties), Appendix D (Modifications), and Appendix E (Benchmarks). This Cover Page serves to Identify the Parties to this Agreement:

NATIONAL INSTITUTES OF HEALTH CENTERS FOR DISEASE CONTROL PATENT LICENSE AGREEMENT—EXCLUSIVE COVER PAGE

Patent License Agreement • June 29th, 2004 • Xenova Group PLC • Biological products, (no disgnostic substances) • District of Columbia

• Contract Type
  Patent License Agreement
• Filed
  June 29th, 2004
• Company
  Xenova Group PLC
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  District of Columbia

Licensee agrees to the following Benchmarks for its performance under this Agreement and, within ten (10) days of achieving a Benchmark, shall notify PHS that the Benchmark has been achieved.